The DOI matches its Crossref record; 172 of the 175 references it cites were found in a registry or an index.
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Abstract
Synthetic oleanane triterpenoids and rexinoids are two new classes of multifunctional drugs. They are neither conventional cytotoxic agents, nor are they monofunctional drugs that uniquely target single steps in signal transduction pathways. Synthetic oleanane triterpenoids have profound effects on inflammation and the redox state of cells and tissues, as well as being potent anti-proliferative and pro-apoptotic agents. Rexinoids are ligands for the nuclear receptor transcription factors known as retinoid X receptors. Both classes of agents can prevent and treat cancer in experimental animals. These drugs have unique molecular and cellular mechanisms of action and might prove to be synergistic with standard anti-cancer treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synthetic triterpenoids (TP), analogues of oleanolic acid, are powerful inhibitors of oxidative stress and cellular inflammatory processes, and thus may be neuroprotective in neurodegeneration.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [181]
In the citing paper
“Synthetic TP compounds are potent inducers of the antioxidant response element (ARE)–Nrf2–Keap1 signaling pathway and are useful in a variety of the cancers including leukemia, multiple myeloma, osteosarcoma, breast and lung cancer181.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [181]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Research works printed but not linked: 1
- Suh, N. et al. Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268. Clin. Cancer Res. 8, 3270–3275 (2002). The first report of the combination of a rexinoid and a SERM for prevention and treatment of breast cancer.
Cited by
Sorted by citations
Items 101–200 of 651
Li, W., Guo, Y., Zhang, C., Wu, R., Yang, Y., Gaspar, J. M., & Kong, A. T. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00413 · Cited by 101
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects
Zoja, C., Corna, D., Nava, V., Locatelli, M., Abbate, M., Gaspari, F., Carrara, F., Sangalli, F., Remuzzi, G., & Benigni, A. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00376.2012 · Cited by 101
“Bardoxolone methyl and related synthetic triterpenoid analogs showed promise as therapeutic agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress (15, 27).”
BackgroundInfluentialKa, S., Lin, J., Lin, T.-J., Liu, F., Chao, L. K., Ho, C., Yeh, L., Sytwu, H., Hua, K., & Chen, A. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0844-6 · Cited by 100
“A selective Nrf2 agonist, bardoxolone, has been found to enhance the magnitude of proteinuria in a rat model of diabetic nephropathy [47], but was found to be beneficial in the prevention and therapy of tissue injury in an animal model of cancer [48, 49].”
BackgroundGarofalo, R. P., Kolli, D., & Casola, A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4307 · Cited by 103
“Further derivatization of CDDO to yield imidazolides (CDDO-Im), amides (methyl amide, CDDO-MA; ethyl amide, CDDO-EA), or a dinitrile (Di-CDDO) significantly increases biological activity (150).”
Ichikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008391 · Cited by 99
“However; it has been recently demonstrated that activation of nuclear factor-erythroid (NF-E) 2–related factor 2 (Nrf2) signaling is critical for the SO-mediated anti-inflammatory and anti-carcinogenic activities [4].”
BackgroundInfluentialRespiratory Viral Infections and Subversion of Cellular Antioxidant Defenses
Casola, A. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000141 · Cited by 99
Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
Nakagami, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7469326 · Cited by 100
“A breakthrough in the study of Nrf2 activators was the finding that some synthetic oleanane triterpenoids have CD values in the subnanomolar range [45, 46].”
BackgroundProteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR
Yore, M. M., Kettenbach, A. N., Sporn, M. B., Gerber, S. A., & Liby, K. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022862 · Cited by 98
Self-citationMyeloid‐derived suppressor cells as effectors of immune suppression in cancer
Pyzer, A. R., Cole, L., Rosenblatt, J. M., & Avigan, D. (2016) · International Journal of Cancer · doi:10.1002/ijc.30232 · Cited by 101
Martín, R., Tavares, J. C., Hernández, M., Arnés, M., Ruíz-Gutiérrez, V., & Nieto, M. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.002 · Cited by 96
“inflammatory and neuroprotective activities, targeting multiple cytokines and key signaling molecules important in neurodegenerative disorders [13,16,22].”
BackgroundOleanolic acid enhances insulin secretion in pancreatic β‐cells
Teodoro, T., Zhang, L., Alexander, T. R., Yue, J. T. Y., Vranić, M., & Volchuk, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.026 · Cited by 96
“Synthetic oleanane triterpenoids derived from oleanolic acid having two carbonyl bonds have recently been synthesized that have more potent properties than the parent molecule [5,19].”
BackgroundJutooru, I., Chadalapaka, G., Abdelrahim, M., Basha, R. M., Samudio, I. J., Konopleva, M. Y., Andreeff, M., & Safe, S. H. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064451 · Cited by 92
“CDDO-Im-dependent anticarcinogenic activity in pancreatic cancer cells has been linked to its mitochondriotoxic activity (Samudio et al., 2005), which was characterized by decreased MMP and GSH and induction of ROS, and these responses were blocked in cells cotreated with thiol antioxidants.”
BackgroundResultInfluentialNrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A
Wei, Y., Gong, J., Xu, Z., Thimmulappa, R. K., Mitchell, K. L., Welsbie, D. S., Biswal, S. S., & Duh, E. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512683112 · Cited by 92
“Synthetic triterpenoids have been developed as potent inducers of Nrf2 that act by promoting its nuclear translocation (33, 34).”
BackgroundTherapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Alam, M., Ali, S., Ahmed, S., Elasbali, A. M., Adnan, M., Islam, A., Hassan, M. I., & Yadav, D. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212162 · Cited by 91
“Hence, the pre-dominant 3S predecessor is changed into a cationic dammarenyl construction undergoing chain growth, making this third separate ring present in the amyrin skeleton, a nucleus in UA [60].”
BackgroundDissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics
Mendoza‐Parra, M. A., Walia, M., Sankar, M., & Gronemeyer, H. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.73 · Cited by 91
“Apart from their impact on physiology, RARs and RXRs have major promise for therapy and prevention of cancer and other diseases, and several therapeutic paradigms have been established (Altucci et al, 2007; Liby et al, 2007; Shankaranarayanan et al, 2009; de The and Chen, 2010; Zhang et al, 2010).”
BackgroundSynthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
Liby, K. T., Royce, D. B., Risingsong, R., Williams, C. R., Maitra, A., Hruban, R. H., & Sporn, M. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0197 · Cited by 90
Self-citationD’Uva, G., Baci, D., Albini, A., & Noonan, D. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.10.013 · Cited by 90
Hancock, R., Schaap, M., Pfister, H., & Wells, G. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob40249e · Cited by 91
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 95
“These compounds inhibit cancer cell proliferation by downregulating cyclin D1 and upregulating caveolin-1, while simultaneously activating both intrinsic and extrinsic apoptotic pathways to induce cell death, including common epithelial carcinomas, myeloma, leukemia, and sarcoma [464,466,467].”
Zhao, C., Yin, S., Dong, Y., Guo, X., Fan, L., Ye, M., & Hu, H. (2012) · Autophagy · doi:10.4161/auto.22805 · Cited by 88
Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
Caldwell, C. C., Yao, J., & Brinton, R. D. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0324-8 · Cited by 86
“triterpenoids have been demonstrated to induce expression of Nrf2 and to protect against cell death in both in vitro and in vivo experiments [160, 161].”
BackgroundMitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease
Dumont, M., Lin, M. T. S., & Beal, M. F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100507 · Cited by 85
“Induction of the Nrf2/ARE pathway by TPs is due to disruption of the binding between Nrf2 and Keap1, allowing Nrf2 to translocate to the nucleus [107].”
BackgroundThe Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
Reddy, S. P. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160925 · Cited by 84
Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives
Hayes, M., & Ferruzzi, M. G. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.06.010 · Cited by 95
Pitha, I., Liby, K. T., Royce, D. B., & Sporn, M. B. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3648 · Cited by 83
Self-citationA review of the molecular design and biological activities of RXR agonists
de Almeida, N. R., & Conda‐Sheridan, M. (2019) · Medicinal Research Reviews · doi:10.1002/med.21578 · Cited by 84
Ding, C., Zhang, Y., Chen, H., Yang, Z., Wild, C., Ye, N., Ester, C. D., Xiong, A., White, M. A., Shen, Q., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401248x · Cited by 83
Triterpenoids of Marine Origin as Anti-Cancer Agents
Li, Y.-X., Himaya, S. W. A., & Kim, S. (2013) · Molecules · doi:10.3390/molecules18077886 · Cited by 81
“[10,11].”
Boykin, C., Zhang, G., Chen, Y.-H., Zhang, R.-W., Fan, X.-E., Yang, W.-M., & Lu, Q. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.10 · Cited by 80
“…have become a subject of intense investigation because this triterpene family induces cancer cell death (Wu et al, 2002; Sun et al, 2005; Liby et al, 2007) and many of them inhibit the phosphorylation of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3…”
BackgroundZhou, R., Zhang, Z., Zhao, L., Jia, C., Xu, S., Mai, Q., Lu, M., Huang, M., Wang, L., Wang, X., et al. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21311 · Cited by 81
“It has been well established that synthetic triterpenoids and its derivatives are an extremely potent class of new anti-cancer therapeutic agents, either alone or in combination with conventional chemotherapy in cancers that exhibit resistance to standard agents.(11) But the mechanisms involved in anti-cancer effects…”
BackgroundTriterpenes in cancer: significance and their influence
Gill, B. S., Kumar, S., & Navgeet (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4032-9 · Cited by 82
Chapter 3 The TRAIL to Targeted Therapy of Breast Cancer
Rahman, M., Pumphrey, J. G., & Lipkowitz, S. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)03003-6 · Cited by 86
“Triterpenoids are naturally occurring compounds synthesized by many plants and two of the naturally occurring triterpenoids, oleanolic acid, and ursolic acid, have weak anti-inflammatory and antitumor effects in vivo (Liby et al., 2007).”
BackgroundTriterpenoids as reversal agents for anticancer drug resistance treatment
Yan, X., Gong, L.-H., Zheng, F.-Y., Cheng, K., Chen, Z., & Shi, Z. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.018 · Cited by 81
Wang, Y., Zhe, H., & Zhao, R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-30 · Cited by 82
“It has been estimated that more than 20,000 triterpenoids exist in nature [7].”
BackgroundAdebayo, S. A., Ondua, M., Shai, J. L., & Lebelo, S. L. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s199377 · Cited by 82
“42 Determination of the speci fi c class of phyto-compound responsible for the observed biological activity was beyond the scope of this work.”
Inhibition of IκB Kinase-β and Anticancer Activities of Novel Chalcone Adamantyl Arotinoids
Lorenzo, P., Álvarez, R., Ortiz, M. A., Álvarez, S., Piedrafita, F. J., & de Lera, Á. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800285f · Cited by 79
Hong, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i17.2080 · Cited by 79
Aminzadeh, M. A., Reisman, S. A., Vaziri, N. D., Khazaeli, M., Yuan, J. J., & Meyer, C. J. (2013) · Xenobiotica · doi:10.3109/00498254.2013.852705 · Cited by 79
“Bardoxolone methyl and its analogs are oleanolic acid-derived synthetic triterpenoid compounds which potently activate the Nrf2-Keap1 pathway (Dinkova-Kostova et al., 2005; Liby et al., 2007).”
BackgroundInfluentialIntroduction to the Different Classes of Natural Products
Springob, K., & Kutchan, T. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-85498-4_1 · Cited by 84
Liby, K. T., Risingsong, R., Royce, D. B., Williams, C. R., Yore, M. M., Honda, T., Gribble, G. W., Lamph, W. W., Vannini, N., Sogno, I., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0040 · Cited by 77
Self-citationTissue‐specific study across the stem reveals the chemistry and transcriptome dynamics of birch bark
Alonso‐Serra, J., Safronov, O., Lim, K., Fraser‐Miller, S. J., Blokhina, O. B., Campilho, A., Chong, S., Fagerstedt, K., Haavikko, R., Helariutta, Y., et al. (2019) · New Phytologist · doi:10.1111/nph.15725 · Cited by 76
Epigenetics/epigenomics of triterpenoids in cancer prevention and in health
Li, S. N., Kuo, H. D., Yin, R., Wu, R., Liu, X., Wang, L., Hudlikar, R. R., Peter, R. M., & Kong, A. T. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113890 · Cited by 77
Ryu, K., Choy, E., Cao, Y., Susa, M., Hornicek, F. J., Mankin, H. J., & Duan, Z. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21088 · Cited by 75
“CDDO-Me is able to induce differentiation and suppress the growth of tumor cells, and it is also capable of inducing apoptosis in the cancer cells that are resistant to conventional chemotherapeutic agents.(46) Recent reports using CDDO-Me to inhibit Stat3 pathway in cancer cells resulting in a dramatic induction of a…”
BackgroundZeng, X., Wang, Y., Cantley, J., Iseli, T. J., Molero, J. C., Hegarty, B. D., Kraegen, E. W., Yang, Y., & Ye, J.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042115 · Cited by 78
“These findings are encouraging because triterpenoids are a rich natural source for drug discovery, with more than 20,000 of them known to exist in plants [15].”
BackgroundDuan, Z., Ames, R. Y., Ryan, M. B., Hornicek, F. J., Mankin, H. J., & Seiden, M. V. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0785-8 · Cited by 75
“SOCS-1 and SHP-1 have been shown to inhibit Stat3 phosphorylation [17,24,28].”
BackgroundResultInfluentialGonçalves, B. M. F., Cardoso, D., & Ferreira, M. U. (2020) · Molecules · doi:10.3390/molecules25153364 · Cited by 80
Camer, D., Yu, Y., Szabo, A., & Huang, X. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300861 · Cited by 76
“Bardoxolone methyl has successfully completed phase I and II of human clinical trials for treating CKD in type 2 diabetics, and phase I clinical trials for the treatment of leukaemia and solid tumours [68], indicating its potential in treating multiple diseases.”
BackgroundMetabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals
Tosetti, F., Noonan, D. M., & Albini, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24677 · Cited by 73
“This is the case for the oleanane triterpenoids 2cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its methyl derivative CDDO-Me (RTA-402) synthesized from the natural compounds found in berry fruits and apples and for N-(4hydroxyphenyl)retinamide (fenretinide or 4HPR), a synthetic derivative of Vitamin A, wh…”
BackgroundTumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis
Secchiero, P., & Zauli, G. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f15fa6 · Cited by 73
Mouhid, L., Corzo‐Martínez, M., Torres, C. F., Vázquez, L., Reglero, G., Fornari, T., & de Molina, A. R. (2017) · Journal of Oncology · doi:10.1155/2017/7351976 · Cited by 76
“In the last years, triterpenoids have demonstrated antitumor efficacy against breast, leukemia, multiple myeloma, and non-small cell lung carcinomas, specially affecting cell proliferation [34, 35].”
BackgroundAi, Y., Kang, F., Huang, Z., Xue, X., Lai, Y., Peng, S., Tian, J., & Zhang, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019302 · Cited by 71
Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia‐reperfusion
Xu, Z., Cho, H., Hartsock, M. J., Mitchell, K. L., Gong, J., Wu, L., Wei, Y., Wang, S., Thimmulappa, R. K., Sporn, M. B., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13064 · Cited by 71
Self-citationLi, Y., Wei, H., Qi, L., Chen, J., Ren, M., & Li, P. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4728 · Cited by 71
Identification of a Naturally Occurring Rexinoid, Honokiol, That Activates the Retinoid X Receptor
Kotani, H., Tanabe, H., Mizukami, H., Makishima, M., & Inoue, M. (2010) · Journal of Natural Products · doi:10.1021/np100120c · Cited by 69
Reddy, N. M., Vegiraju, S., Yates, M. S., Kleeberger, S. R., Hassoun, P. M., Yamamoto, M. P., Liby, K. T., Sporn, M. B., Kensler, T. W., & Reddy, S. P. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0670oc · Cited by 70
“We have previously demonstrated that a synthetic triterpenoid compound CDDO-Im (1-[2-cyano-3-,12dioxooleana-1,9(11)-dien-28-oyl] imidazole) disrupts the cytosolic Keap1:Nrf2 interactions and robustly induces cytoprotective gene expression via Nrf2-ARE signaling in several tissues, including the lung (16-18).”
BackgroundSelf-citationRole of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
Cui, W., Min, X., Xu, X., Du, B., & Luo, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3797802 · Cited by 68
“The most well-studied promising candidate Nrf2 activator is bardoxolone methyl (BM), which has been used not only for cancer [115] but also for many other oxidative stress and inflammation-involved chronic diseases [116].”
BackgroundMou, W., Xu, Y., Ye, Y., Chen, S., Li, X., Gong, K., Liu, Y., Chen, Y., Li, X., Tian, Y., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.004 · Cited by 65
Lin, H., Haegele, J. A., Disare, M. T., Lin, Q., & Aye, Y. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5132648 · Cited by 65
Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases
Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0474-4 · Cited by 66
Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease
Fulda, S., & Kroemer, G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4078 · Cited by 66
Wang, X., Stafford, W. C., Mazurkiewicz, M., Fryknäs, M., Brjnic, S., Zhang, X., Gullbo, J., Larsson, R. L., Arnér, E. S. J., D’Arcy, P., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091322 · Cited by 65
“The homo-triterpenoid bardoxolone methyl (RTA402; methyl (4aS,6aR,6bS,8aR,12aR,14aR,14bS)-11-isocyano2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14bdecahydropicene-4a-carboxylate) contains an a,b-unsaturated carbonyl unit (Liby et al., 2007) and is in clinical development for the treatment of diabet…”
BackgroundMicrobial Transformation of Triterpenoids
Parra, A., Rivas, F., García‐Granados, A., & Martı́nez, A. (2009) · Mini-Reviews in Organic Chemistry · doi:10.2174/157019309789371569 · Cited by 64
p38 MAPK Signaling Mediates Mitochondrial Apoptosis in Cancer Cells Induced by Oleanolic Acid
Liu, J., Wu, N., Ma, L., Zhong, J., Liu, G., Zheng, L., & Lin, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4519 · Cited by 64
Synthesis of new potential anticancer agents based on 4-thiazolidinone and oleanane scaffolds
Kaminskyy, D. V., Bednarczyk–Cwynar, B., Vasylenko, O., Kazakova, O. B., Zimenkovsky, B. S., Zaprutko, L., & Lesyk, R. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9893-9 · Cited by 63
“, 2000a, b), antiviral (6) (Cichewicz and Kouzi, 2004), antibacterial and anticancer (7) activities (Honda et al., 2000a; Liby et al., 2007; Liu 2005; Couch et al., 2005) (Fig.”
BackgroundLiao, D., Liu, Z., Wrasidlo, W., Luo, Y., Nguyen, G., Chen, T., Xiang, R., & Reisfeld, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1264 · Cited by 63
“Synthetic triterpenoids are a class of multifunctional inhi - bitors shown to suppress solid tumor growth through inacti - vation of STATs ( 11 ) .”
InfluentialBenefits of Black Cohosh (Cimicifuga racemosa) for Women Health: An Up-Close and In-Depth Review
Mohapatra, S., Iqubal, A., Ansari, M. J., Jan, B., Zahiruddin, S., Mirza, M. A., Ahmad, S., & Iqbal, Z. (2022) · Pharmaceuticals · doi:10.3390/ph15030278 · Cited by 62
“Triterpenes and saponins have been shown to possess a range of biological actions such as anti-inflammatory and anti-cancer effects, and can promote or induce apoptosis [24,28].”
BackgroundActivation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβ
Iseli, T. J., Turner, N. A., Zeng, X., Cooney, G. J., Kraegen, E. W., Yao, S., Ye, Y., James, D. E., & Ye, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062309 · Cited by 63
“Alternatively, as BMTs are structurally similar to bile acids [44], they could agonise the bile acid receptor TGR5, another G-protein coupled receptor which has antidiabetic properties, though this has not been linked to CaMKKb or AMPK activities [45].”
BackgroundSalvador, J. A. R., Pinto, R. M. A., Santos, R. C., Roux, C. L., Beja, A. M., & Paixão, J. A. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b814448f · Cited by 62
Woo, S. M., Seo, S. U., Min, K., Im, S., Nam, J., Chang, J., Kim, S., Park, J., & Kwon, T. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051309 · Cited by 61
“Corosolic acid is a pentacyclic triterpenoid discovered in traditional Asian medical herbs such as Lagerstroemia speciose [8,9].”
BackgroundRyu, K., Susa, M., Choy, E., Cao, Y., Hornicek, F. J., Mankin, H. J., & Duan, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-187 · Cited by 61
“The results are consistent with a series of studies showing that CDDO-related compounds are not monofunctional drugs that strictly target single steps in signal transduction pathways [32,40,48].”
InfluentialTrougakos, I. P., Sesti, F., Tsakiri, E. N., & Gorgoulis, V. G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.024 · Cited by 63
Xing, Y., Niu, T., Wang, W., Li, J., Li, S., Janicki, J. S., Ruiz, S., Meyer, C. J., Wang, X. L., Tang, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044899 · Cited by 61
“Derivatives of oleanolic acid are relatively non-toxic and cytoprotective, and have emerged as attractive drug candidates for the treatment of various diseases [27].”
BackgroundDietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
Corbi, G., Conti, V., Davinelli, S., Scapagnini, G., Filippelli, A., & Ferrara, N. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00364 · Cited by 63
“…share common properties and play an important role to activate the phase II detoxifying and antioxidant enzymes like HO-1, glutathione peroxidase (GSH-Px), and glutathione-S-transferase (GST) by targeting the common transcription factor Nrf2 (Liby et al., 2007; Tosetti et al., 2009).”
BackgroundDu, J., Wang, L., Huang, X., Zhang, N., Long, Z., Yang, Y. Q., Zhong, F., Zheng, B., Lan, W., Lin, W., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153551 · Cited by 61
New jasmonate analogues as potential anti-inflammatory agents
Dang, H. T., Lee, H. J., Yoo, E. S., Hong, J., Bao, B., Choi, J. S., & Jung, J. H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.050 · Cited by 60
Xu, S., Wang, G., Peng, W., Xu, Y., Zhang, Y., Ge, Y., Jing, Y., & Gong, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-40934-7 · Cited by 60
Janakiram, N. B., Cooma, I., Swamy, M. V., Patlolla, J. M. R., Steele, V. E., & Rao, C. V. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9582-7 · Cited by 59
“Past studies have reported the anti-inflammatory, anti-tumor promoting properties of the several natural triterpenes like ONA, ursolic acid, lupeol and glycyrrhetinic acid (36,37).”
BackgroundDeveloping Phytocompounds from Medicinal Plants as Immunomodulators
Wen, C.-C., Chen, H., & Yang, N. (2012) · Advances in botanical research · doi:10.1016/b978-0-12-394591-4.00004-0 · Cited by 67
“There are more than 20,000 naturally occurring triterpenoids which have cyclic structures (Ajikumar et al., 2008; Liby et al., 2007) .”
Enzymatic biotransformation of terpenes as bioactive agents
Sultana, N., & Saify, Z. S. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.727411 · Cited by 58
“Hydroxylation was found to be the most common reaction in sesquiterpenes pyrethrosin (5), plectranthone (6)(62), costunolide (8)(38,63) and partheniol (7) (Scheme 1) afforded mainly their hydroxylated derivatives with various fungal strains.”
BackgroundMARUYAMA, M. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000172 · Cited by 58
Ye, X., Wu, H., Sheng, L., Liu, Y., Ye, F., Wang, M., Zhou, H., Su, Y., & Zhang, X.-K. (2019) · Nature Communications · doi:10.1038/s41467-019-09375-8 · Cited by 58
Castiglione, G. M., Xu, Z., Zhou, L., & Duh, E. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16129-4 · Cited by 63
Ursolic Acid Analogs as Potential Therapeutics for Cancer
Panda, S. S., Thangaraju, M., & Lokeshwar, B. L. (2022) · Molecules · doi:10.3390/molecules27248981 · Cited by 59
“These are a large and structurally diverse group of NPs having about 200 distinct skeletons, and more than 20,000 triterpenoids are isolated and identified from nature [14,15].”
BackgroundCDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
Kim, E., Deng, C., Sporn, M. B., Royce, D. B., Risingsong, R., Williams, C. R., & Liby, K. T. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0359 · Cited by 57
“Rather, the pentacyclic scaffold of CDDOMe, together with the exocyclic methyl groups of this triterpenoid, provide a highly stereospecific platform for interaction with unique cysteine residues on target proteins (20, 30, 31).”
BackgroundSelf-citationLiby, K. T., Risingsong, R., Royce, D. B., Williams, C. R., Ma, T., Yore, M. M., & Sporn, M. B. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0085 · Cited by 57
“Although it has not yet been used in clinical trials, LG 100268 has been widely used in many experimental studies and has produced excellent preclinical results in rodents for more than 10 years (7).”
BackgroundMethodInfluentialSelf-citationBetulin and betulinic acid in cancer research
Hordyjewska, A., Ostapiuk, A., & Horecka, A. (2018) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/92743 · Cited by 57
“Therefore, triterpenoids form approximately 50% of the total known amount of terpenes [2, 4].”
BackgroundThe synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Vannini, N., Lorusso, G., Cammarota, R., Barberis, M. C. P., Noonan, D. M., Sporn, M. B., & Albini, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0451 · Cited by 56
“oleanolic acid have been synthesized recently (8), and two of them, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its methyl ester (CDDO-Me), are now on”
BackgroundSelf-citationRufino‐Palomares, E. E., Pérez‐Jiménez, A., Reyes‐Zurita, F. J., Garcı́a-Salguero, L., Mokhtari, K., Herrera-Merchan, A., Medina, P. P., Peragón, J., & Lupiáñez, J. A. (2015) · Current Organic Chemistry · doi:10.2174/1385272819666150119225952 · Cited by 56
Multifunctional pentacyclic triterpenoids as adjuvants in cancer chemotherapy: a review
Kamble, S. M., Goyal, S. N., & Patil, C. R. (2014) · RSC Advances · doi:10.1039/c4ra02784a · Cited by 56
Wang, H., Xu, R., Shi, Y., Si, L., Jiao, P., Fan, Z., Xu, H., Wu, X., Zhou, X., Yu, F., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.005 · Cited by 55
Current Evidence on the Anticancer Potential of Chios Mastic Gum
Giaginis, C., & Theocharis, S. E. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.607546 · Cited by 54
“Both synthetic and naturally occurring triterpenoid analogues have been evaluated for their anticancer activity ( 57 – 61 ).”
Yang, S., Hua, K., Lin, Y., Chen, A., Chang, J., Chao, L. K., Ho, C., & Ka, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074871 · Cited by 55
“However, recently studies using a highly selective Nrf2 agonist bardoxolone suggest that bardoxolone actually worsened proteinuria [57,58], although bardoxolone and related synthetic triterpenoid analogs have been shown to have beneficial effects on prevention and therapy of tissue injury mediated by inflammatory and…”
BackgroundYap, W. H., Yew, W. T., Hong, P., Soo, K. K., Hoon, L., Chieng, Y., & Mooi, L. (2010) · Planta Medica · doi:10.1055/s-0030-1250203 · Cited by 54
Mendes, V. I. S., Bartholomeusz, G. A., Ayres, M., Gandhi, V. V., & Salvador, J. A. R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.045 · Cited by 54
Tilekar, K. N., Shelke, O., Upadhyay, N., Lavecchia, A., & Ramaa, C. S. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131767 · Cited by 53
Synthesis and Pro‐Apoptotic Activity of Novel Glycyrrhetinic Acid Derivatives
Logashenko, E. B., Salomatina, O. V., Markov, A. V., Викторовна, К. Д., Salakhutdinov, N. F., Tolstikov, G. A., Vlassov, V. V., & Аркадьевна, З. М. (2011) · ChemBioChem · doi:10.1002/cbic.201000618 · Cited by 53
Synthesis and Anti‐HCV Entry Activity Studies of β‐Cyclodextrin–Pentacyclic Triterpene Conjugates
Xiao, S., Wang, Q., Si, L., Shi, Y., Wang, H., Yu, F., Zhang, Y., Li, Y., Zheng, Y., Zhang, C., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300545 · Cited by 53
Wei, G., Luan, W., Wang, S., Cui, S., Fengran, L., Liu, Y., Liu, Y., & Cheng, M. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01605j · Cited by 53
Anticancer Effects of Seaweed-Derived Bioactive Compounds
Lee, H., Selvaraj, B., & Lee, J. W. (2021) · Applied Sciences · doi:10.3390/app112311261 · Cited by 57
Liby, K. T., Yore, M. M., Roebuck, B. D., Baumgartner, K. J., Honda, T., Sundararajan, C., Yoshizawa, H., Gribble, G. W., Williams, C. R., Risingsong, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1123 · Cited by 52
Self-citation
Metadata
- Authors
- Liby, K. T., Yore, M. M., & Sporn, M. B.
- Affiliations
- Dartmouth College (US)
- Corresponding author
- Sporn, Michael B.
- ORCID
- Liby, Karen T.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04-19
- Volume
- 7
- Issue
- 5
- Pages
- 357-369
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2000178617
- Cited by
- 637
- References
- 175
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 23 · 2023: 30 · 2022: 32 · 2021: 23 · 2020: 28 · 2019: 27 · 2018: 15 · 2017: 35 · 2016: 36 · 2015: 44 · 2014: 47 · 2013: 43 · 2012: 48
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Phytochemical Studies and Bioactivities
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Effects of Natural Compounds
- Keywords
- oleanane triterpenoids, rexinoids, cancer prevention, cancer therapy, retinoid X receptor, antiproliferative agents, apoptosis, inflammation, redox state, multi-target drugs, drug synergy
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antineoplastic Agents, Dose-Response Relationship, Drug, Humans, Neoplasms, Oleanolic Acid, Anticarcinogenic Agents, Retinoid X Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review